BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng X, Lou QY, Yang WY, Wang YR, Chen R, Wang L, Xu T, Zhang L. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. Cancer Commun (Lond) 2021. [PMID: 34289530 DOI: 10.1002/cac2.12194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Anees FF, Sekar D. Implications of STAT signaling pathways and its associated molecules in the treatment of Oral Squamous Cell Carcinoma (OSCC). J Stomatol Oral Maxillofac Surg 2023;:101392. [PMID: 36681122 DOI: 10.1016/j.jormas.2023.101392] [Reference Citation Analysis]
2 Tang J, Wu X, Cheng B, Lu Y. Identification of a polyamine-related signature and six novel prognostic biomarkers in oral squamous cell carcinoma. Front Mol Biosci 2023;10:1073770. [PMID: 36733434 DOI: 10.3389/fmolb.2023.1073770] [Reference Citation Analysis]
3 Huni KC, Cheung J, Sullivan M, Robison WT, Howard KM, Kingsley K. Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines. Int J Mol Sci 2023;24. [PMID: 36674758 DOI: 10.3390/ijms24021244] [Reference Citation Analysis]
4 Xue Y, Jiang X, Wang J, Zong Y, Yuan Z, Miao S, Mao X. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomark Res 2023;11:2. [PMID: 36600313 DOI: 10.1186/s40364-022-00433-w] [Reference Citation Analysis]
5 Cui H, You Y, Cheng GW, Lan Z, Zou KL, Mai QY, Han YH, Chen H, Zhao YY, Yu GT. Advanced materials and technologies for oral diseases. Sci Technol Adv Mater 2023;24:2156257. [PMID: 36632346 DOI: 10.1080/14686996.2022.2156257] [Reference Citation Analysis]
6 Zhang L, Lin S, Zhang Z, Yan C, Liu F. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway. Clin Transl Oncol 2023. [PMID: 36593383 DOI: 10.1007/s12094-022-02980-y] [Reference Citation Analysis]
7 Yang X, Liu L, Shen X, Shi L, Liu W. Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs. Oral Oncol 2023;136:106277. [PMID: 36508884 DOI: 10.1016/j.oraloncology.2022.106277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Meng X, Wu T, Lou Q, Niu K, Jiang L, Xiao Q, Xu T, Zhang L. Optimization of CRISPR–Cas system for clinical cancer therapy. Bioengineering & Transla Med 2022. [DOI: 10.1002/btm2.10474] [Reference Citation Analysis]
9 Hu Y, Lv F, Li N, Yuan X, Zhang L, Zhao S, Jin L, Qiu Y. Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3. FEBS Open Bio 2023;13:195-208. [PMID: 36468944 DOI: 10.1002/2211-5463.13532] [Reference Citation Analysis]
10 Wang X, Dong W, Zhang Y, Huo F. m7G-related lncRNAs are potential biomarkers for predicting prognosis and immune responses in patients with oral squamous cell carcinoma. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1013312] [Reference Citation Analysis]
11 Bai J, Wu L, Wang X, Wang Y, Shang Z, Jiang E, Shao Z. Roles of Mitochondria in Oral Squamous Cell Carcinoma Therapy: Friend or Foe? Cancers (Basel) 2022;14. [PMID: 36497206 DOI: 10.3390/cancers14235723] [Reference Citation Analysis]
12 Chang X, Chen Y, Cui D, Wang Y, Zhou Y, Zhang X, Tang G. Propionate-producing Veillonella parvula regulates the malignant properties of tumor cells of OSCC.. [DOI: 10.21203/rs.3.rs-2197348/v1] [Reference Citation Analysis]
13 Peng L, Yan Q, Chen Z, Hu Y, Sun Y, Miao Y, Wu Y, Yao Y, Tao L, Chen F, Li H, Xu T. Research progress on the role of cholesterol in hepatocellular carcinoma. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175410] [Reference Citation Analysis]
14 Sun D, Shang D, Miao P, Jiang Z, Chen Y, Gao J. MiR-4284 inhibits sensitivity to paclitaxel in human ovarian carcinoma SKOV3ip1 and HeyA8 cells by targeting DMC1. Anticancer Drugs 2022;33:701-9. [PMID: 35946537 DOI: 10.1097/CAD.0000000000001314] [Reference Citation Analysis]
15 Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022;65:100866. [DOI: 10.1016/j.drup.2022.100866] [Reference Citation Analysis]
16 Yu C, Li L, Wang S, Xu Y, Wang L, Huang Y, Hieawy A, Liu H, Ma J. Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shao Z, Wang X, Li Y, Hu Y, Li K. The role of long noncoding RNAs as regulators of the epithelial–Mesenchymal transition process in oral squamous cell carcinoma cells. Front Mol Biosci 2022;9:942636. [DOI: 10.3389/fmolb.2022.942636] [Reference Citation Analysis]
18 Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother 2022;154:113609. [PMID: 36037786 DOI: 10.1016/j.biopha.2022.113609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Peña-flores JA, Bermúdez M, Ramos-payán R, Villegas-mercado CE, Soto-barreras U, Muela-campos D, Álvarez-ramírez A, Pérez-aguirre B, Larrinua-pacheco AD, López-camarillo C, López-gutiérrez JA, Garnica-palazuelos J, Estrada-macías ME, Cota-quintero JL, Barraza-gómez AA. Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma. Front Oncol 2022;12:965628. [DOI: 10.3389/fonc.2022.965628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang L, Wang J, Tan B, Yin Y, Kang Y, Li S. The Association of lncRNA and mRNA Changes in Adipose Tissue with Improved Insulin Resistance in Type 2 Obese Diabetes Mellitus Rats after Roux-en-Y Gastric Bypass. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/8902916] [Reference Citation Analysis]
21 Zhang L, Wang X. An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma. Front Genet 2022;13:870133. [DOI: 10.3389/fgene.2022.870133] [Reference Citation Analysis]
22 Zhao P, Qiu H, Wei Q, Li Y, Gao L, Zhao P. Anti-tumor effect of novel amino acid Schiff base nickel (II) complexes on oral squamous cell carcinoma cells (CAL-27) in vitro. Mol Cell Toxicol 2022. [DOI: 10.1007/s13273-022-00255-9] [Reference Citation Analysis]
23 Guo J, Liu X, Zeng Y, Liang T, Tang K, Guo J, Zheng W. Comprehensive Analysis of the Effects of Genetic Ancestry and Genetic Characteristics on the Clinical Evolution of Oral Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:678464. [PMID: 34950653 DOI: 10.3389/fcell.2021.678464] [Reference Citation Analysis]
24 Lu Y, Lin J, Duan M, Rui Y, Zheng H, Zhu L, Zhu X, Wei J. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway. Anal Cell Pathol (Amst) 2021;2021:5228713. [PMID: 34926131 DOI: 10.1155/2021/5228713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tang J, Fang X, Chen J, Zhang H, Tang Z. Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application. Cancers (Basel) 2021;13:5944. [PMID: 34885054 DOI: 10.3390/cancers13235944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
26 Song S, Xia X, Qi J, Hu X, Chen Q, Liu J, Ji N, Zhao H. Silmitasertib-induced macropinocytosis promoting DDP intracellular uptake to enhance cell apoptosis in oral squamous cell carcinoma. Drug Deliv 2021;28:2480-94. [PMID: 34766543 DOI: 10.1080/10717544.2021.2000677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Xu XF, Yang XK, Song Y, Chen BJ, Yu X, Xu T, Chen ZL. Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies. Pharmacol Res 2021;:105906. [PMID: 34543740 DOI: 10.1016/j.phrs.2021.105906] [Reference Citation Analysis]
28 Liu Z, Zhang L, Chen W, Yuan F, Yang Z, Liu S, Le F. miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase. Bioengineered 2021;12:6201-9. [PMID: 34482792 DOI: 10.1080/21655979.2021.1963908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]